Aug. 31 — Toujing Life shares plunged. Wind shows the stock closed at 16.96
yuan, down 9.98%, with market value about 2.8 bln yuan. The company said the
decline reflects multiple factors and should be a normal correction after
earlier gains. It noted products procured via centralized procurement have
relatively low gross margins, and several core products will enter centralized
procurement in 2024 and 2025. Management said it is stepping up promotion to
increase the share of non‑procurement products, which are concentrated in
autoimmune, fungal and molecular pathology areas.
